학술논문

Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors.
Document Type
article
Source
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12(12)
Subject
Humans
Brain Death
Ventricular Dysfunction
Left
Receptors
Adrenergic
beta-1
Receptors
Adrenergic
beta-2
Prognosis
Retrospective Studies
Graft Survival
Polymorphism
Genetic
Adult
Middle Aged
Tissue Donors
Female
Male
Validation Studies as Topic
Genetics
Cardiovascular
Clinical Research
Neurosciences
Heart Disease
Transplantation
2.1 Biological and endogenous factors
Aetiology
Allograft function
brain death
cardiac allograft
cardiac transplant
cohort study
donor evaluation
donor management
donor outcomes
genetic polymorphism
genotyping
Medical and Health Sciences
Surgery
Language
Abstract
Prior studies have demonstrated associations between beta-adrenergic receptor (βAR) polymorphisms and left ventricular dysfunction-an important cause of allograft nonutilization for transplantation. We hypothesized that βAR polymorphisms predispose donor hearts to LV dysfunction after brain death. A total of 1043 organ donors managed from 2001-2006 were initially studied. The following βAR single nucleotide polymorphisms were genotyped: β1AR 1165C/G (Arg389Gly), β1AR 145A/G (Ser49Gly), β2AR 46G/A (Gly16Arg) and β2AR 79C/G (Gln27Glu). In multivariable regression analyses, the β2AR46 SNP was significantly associated with LV systolic dysfunction, with each minor allele additively decreasing the odds for LV ejection fraction 10 μg/kg/min of dopamine compared to those with the CC and GG genotypes. However, no significant associations were found between βAR SNPs and cardiac dysfunction in 364 donors managed from 2007-2008, perhaps due to changes in donor management, lack of power in this validation cohort, or the absence of a true association. βAR polymorphisms may be associated with cardiac dysfunction after brain death, but these relationships require further study in independent donor cohorts.